ConductScience.org, home

Paper19086074

Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.

Girgenrath M and 4 others. Ann Neurol, 2009. Cited by 69 papers, by iCite.

Cite this record

ConductScience Library. Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy. Papers, record 19086074. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19086074

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.
PubMed
Journal
Ann Neurol
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
1.7
iCite
Revised in PubMed
2025-05-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Girgenrath MMahasweta
2Beermann MLMary Lou
3Vishnudas VKVivek K
4Homma SSachiko
5Miller JBJeffrey Boone

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
DoxycyclineMajor topic
LamininMajor topic
Muscular Dystrophy, AnimalMajor topic
Age Factors
Animals
Apoptosis
CD11b Antigen
Cell Line, Transformed
Disease Models, Animal
Dose-Response Relationship, Drug
Enzyme Inhibitors
In Situ Nick-End Labeling
Male
Mice
Mice, Inbred C57BL
Mice, Transgenic
Motor Activity
Muscle, Skeletal
Mutation
Phosphorylation
Proto-Oncogene Proteins c-akt
Staurosporine
Survival Analysis
Threonine

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AR049496NIAMS NIH HHSUnited StatesR01AR049496PubMed and NIHNIH RePORTER
R01 HL064641NHLBI NIH HHSUnited StatesR01HL064641PubMed and NIHNIH RePORTER
HL064641NHLBI NIH HHSUnited StatesR01HL064641PubMed and NIHNIH RePORTER
AR049496NIAMS NIH HHSUnited StatesR01AR049496PubMed and NIHNIH RePORTER

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116769901Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16769901PubMed
212044978Complement 3 deficiency and oral prednisolone improve strength and prolong survival of laminin alpha2-deficient mice.J Neuroimmunol2002https://conductscience.org/library/papers/12044978PubMed
310381357Activation of caspase-3 apoptotic pathways in skeletal muscle fibers in laminin alpha2-deficient mice.Biochem Biophys Res Commun1999https://conductscience.org/library/papers/10381357PubMed
416678816The AP-1 transcription factor regulates postnatal mammary gland development.Dev Biol2006https://conductscience.org/library/papers/16678816PubMed
512270689Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis.Neurobiol Dis2002https://conductscience.org/library/papers/12270689PubMed
69326364Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy.FEBS Lett1997https://conductscience.org/library/papers/9326364PubMed
715864313Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice.Nat Med2005https://conductscience.org/library/papers/15864313PubMed
811565031An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.Nature2001https://conductscience.org/library/papers/11565031PubMed
910973608Differential phosphorylation at Ser473 and Thr308 of Akt-1 in rat brain following hypoglycemic coma.Brain Res2000https://conductscience.org/library/papers/10973608PubMed
1016443056Tetracyclines: nonantibiotic properties and their clinical implications.J Am Acad Dermatol2006https://conductscience.org/library/papers/16443056PubMed
1118071030Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.Arch Neurol2008https://conductscience.org/library/papers/18071030PubMed
128655577Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death.J Cell Biol1996https://conductscience.org/library/papers/8655577PubMed
13155340927-hydroxystaurosporine (UCN-01) inhibition of Akt Thr308 but not Ser473 phosphorylation: a basis for decreased insulin-stimulated glucose transport.Clin Cancer Res2004https://conductscience.org/library/papers/15534092PubMed
1415569265Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways.J Neurochem2004https://conductscience.org/library/papers/15569265PubMed
1514625552Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency.Nat Genet2003https://conductscience.org/library/papers/14625552PubMed
1611297941IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice.Neuromuscul Disord2001https://conductscience.org/library/papers/11297941PubMed
1710679965Merosin and congenital muscular dystrophy.Microsc Res Tech2000https://conductscience.org/library/papers/10679965PubMed
1817575261VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice.FASEB J2007https://conductscience.org/library/papers/17575261PubMed
1910616210Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency.Lab Invest1999https://conductscience.org/library/papers/10616210PubMed
2011938437Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin).Eur J Hum Genet2002https://conductscience.org/library/papers/11938437PubMed

See all 49 referencesDownload CSV of references

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
39064489Pharmacological Treatments and Therapeutic Targets in Muscle Dystrophies Generated by Alterations in Dystrophin-Associated Proteins.Medicina (Kaunas)2024https://conductscience.org/library/papers/39064489PubMed
37388928Merosin-deficient congenital muscular dystrophy type 1a: detection of LAMA2 variants in Vietnamese patients.Front Genet2023https://conductscience.org/library/papers/37388928PubMed
37021539Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy.Dis Model Mech2023https://conductscience.org/library/papers/37021539PubMed
34568901Lysosomes and the pathogenesis of merosin-deficient congenital muscular dystrophy.Hum Mol Genet2022https://conductscience.org/library/papers/34568901PubMed
34290621Minocycline Treatment Reduces Mass and Force Output From Fast-Twitch Mouse Muscles and Inhibits Myosin Production in C2C12 Myotubes.Front Physiol2021https://conductscience.org/library/papers/34290621PubMed
33869655Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dyW mouse model of MDC1A.Mol Ther Methods Clin Dev2021https://conductscience.org/library/papers/33869655PubMed
32591093Dermatomyositis Developed After Exposure to Epstein-Barr Virus Infection and Antibiotics Use.Am J Med Sci2020https://conductscience.org/library/papers/32591093PubMed
32457577A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD.Front Mol Neurosci2020https://conductscience.org/library/papers/32457577PubMed
32390798LAMA2 Neuropathies: Human Findings and Pathomechanisms From Mouse Models.Front Mol Neurosci2020https://conductscience.org/library/papers/32390798PubMed
32197453Antioxidants Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy.Antioxidants (Basel)2020https://conductscience.org/library/papers/32197453PubMed
31586140Early skeletal muscle pathology and disease progress in the dy3K/dy3K mouse model of congenital muscular dystrophy with laminin α2 chain-deficiency.Sci Rep2019https://conductscience.org/library/papers/31586140PubMed
31308722Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy.Appl Clin Genet2019https://conductscience.org/library/papers/31308722PubMed
29772730At the Crossroads of Clinical and Preclinical Research for Muscular Dystrophy-Are We Closer to Effective Treatment for Patients?Int J Mol Sci2018https://conductscience.org/library/papers/29772730PubMed
29766020Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin.Mol Ther Methods Clin Dev2018https://conductscience.org/library/papers/29766020PubMed
29278895Aberrant Caspase Activation in Laminin-α2-Deficient Human Myogenic Cells is Mediated by p53 and Sirtuin Activity.J Neuromuscul Dis2018https://conductscience.org/library/papers/29278895PubMed
29191403Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies.Matrix Biol2018https://conductscience.org/library/papers/29191403PubMed
28550268Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy.J Neuromuscul Dis2017https://conductscience.org/library/papers/28550268PubMed
28078067α-Linolenic Acid Reduces TNF-Induced Apoptosis in C2C12 Myoblasts by Regulating Expression of Apoptotic Proteins.Eur J Transl Myol2016https://conductscience.org/library/papers/28078067PubMed
27911334Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles.J Neuromuscul Dis2016https://conductscience.org/library/papers/27911334PubMed
27696112Laminin: loss-of-function studies.Cell Mol Life Sci2017https://conductscience.org/library/papers/27696112PubMed

See all 45 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ITGAM3684PubTator's text mininghttps://conductscience.org/library/genes/3684NCBI Gene
LAMA23908PubTator's text mininghttps://conductscience.org/library/genes/3908NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19086074

GET https://conductscience.org/api/papers/v1/19086074/references?page=2